| 000 | 02514 a2200745 4500 | ||
|---|---|---|---|
| 005 | 20250517063721.0 | ||
| 264 | 0 | _c20160308 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1423-0232 | ||
| 024 | 7 |
_a10.1159/000440630 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSugimoto, Kayo | |
| 245 | 0 | 0 |
_aComparison of Daclatasvir and Asunaprevir for Chronic HCV 1b Infection with Telaprevir and Simeprevir plus Peginterferon and Ribavirin, with a Focus on the Prevention of Occurrence and Recurrence of Hepatocellular Carcinoma. _h[electronic resource] |
| 260 |
_bOncology _c2015 |
||
| 300 |
_a42-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCarbamates |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xepidemiology |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHepacivirus _xdrug effects |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xtherapeutic use |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 |
_aIsoquinolines _xtherapeutic use |
| 650 | 0 | 4 |
_aJapan _xepidemiology |
| 650 | 0 | 4 |
_aLiver Neoplasms _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xepidemiology |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aOligopeptides _xtherapeutic use |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xtherapeutic use |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aPyrrolidines |
| 650 | 0 | 4 |
_aRNA, Viral _xgenetics |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
| 650 | 0 | 4 |
_aSimeprevir _xtherapeutic use |
| 650 | 0 | 4 |
_aSulfonamides _xtherapeutic use |
| 650 | 0 | 4 |
_aValine _xanalogs & derivatives |
| 650 | 0 | 4 | _aViral Load |
| 650 | 0 | 4 |
_aalpha-Fetoproteins _xanalysis |
| 700 | 1 | _aKim, Soo Ryang | |
| 700 | 1 | _aKim, Soo Ki | |
| 700 | 1 | _aImoto, Susumu | |
| 700 | 1 | _aTohyama, Madoka | |
| 700 | 1 | _aKim, Ke Ih | |
| 700 | 1 | _aOhtani, Aya | |
| 700 | 1 | _aHatae, Takashi | |
| 700 | 1 | _aYano, Yoshihiko | |
| 700 | 1 | _aKudo, Masatoshi | |
| 700 | 1 | _aHayashi, Yoshitake | |
| 773 | 0 |
_tOncology _gvol. 89 Suppl 2 _gp. 42-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000440630 _zAvailable from publisher's website |
| 999 |
_c25463290 _d25463290 |
||